ArticleFrontiers in pharmacology2020

Nintedanib Inhibits Wnt3a-Induced Myofibroblast Activation by Suppressing the Src/β-Catenin Pathway.

Xiaohe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.